[When is "poor" left ventricular function really poor?].
Explore the source record for details and available documents.
Animals↗
Biomedical subjects
Z Mijailović
Publications and source records attributed to Z Mijailović.
[Personal experience in the diagnosis and treatment of pulmonary embolism].
The 188 patients with pulmonary embolism were treated at the Clinic for Pulmonary Diseases of the M.M.A. in the period 1979-1989. Clinical symptoms and signs, diagnostic procedures and therapy of pulmonary embolism are analysed. The diagnosis is difficult and is suggested by the predisposing factors, symptoms and signs of the disease as well as indirect diagnostic procedures. The contribution of perfusion lung scintigraphy is precious. Deep venous thrombosis of the lower extremities, the source of pulmonary embolism, is commonly clinically absent. The complete cure without complications was achieved in 156 (83%) patients. The most common complications were: early and late recurrences, hematuria and peptic bleeding. The lethal outcome occurred in two cases of basic disseminated malignant disease.
Adult↗
[Problems in the treatment and care of bronchogenic carcinoma].
At the Military Medical Academy about 400-500 patients are hospitalised yearly due to bronchogenic carcinoma which represents about 35-40% of all hospitalized patients. Within a five-year period (1983-1987) there have been examined and treated 887 patients, 406 military and the rest socially insured from Belgrade, Serbia Proper and other regions of Yugoslavia. All types of antitumorous therapy have been applied depending on histologic type and degree of spreading of the disease. After completion of active antitumorous therapy patients were followed up and controlled examinations were performed at the out-patient service with symptomatic therapy at home and temporary hospitalization at the M.M.A. More than 300 patients were hospitalised in the terminal stage of the diseases for general care and symptomamic therapy for approximately 30 days.
Adolescent↗
[Amiodarone--pro and con].
OBJECTIVE: To compare and evaluate the data for and against the use of antiarrhythmic agent amiodarone in known cardiological indications. DATA SOURCES: A MEDLINE search was used to identify the articles dealing with amiodarone, published in the last 15 years. STUDY SELECTION: Articles and studies (uncontrolled retrospective and controlled prospective), as well as case reports speaking decidedly for or against amiodarone were scrutinized. DATA EXTRACTION: Simple search, no particular conditions. CONCLUSIONS: Despite very numerous and serious side effects amiodarone is an extraordinary drug and can be recommended for use, provided that the physician is very well acquainted with all implications of its use. Large number of studies on a significant number of patients has proven the efficacy of amiodarone in supraventricular and ventricular arrhythmias of various origin. The drug is particularly suitable for the treatment of ventricular arrhythmia in patients with serious heart failure and impaired function of the left ventricle. It was successfully used in the treatment of malignant ventricular arrhythmias. In patients after myocardial infarction, intravenously administered amiodarone improved the chances of survival as well as the condition of arrhythmia, preventing spreading of the infarction. It is very convenient against ventricular arrhythmia after the successful resuscitation. Short-lasting intravenous administration of amiodarone does not cause serious side effects.
Amiodarone↗